Found 4887 chains in Genus chains table. Displaying 251 - 300. Applied filters: Proteins

Search results query: 4-Layer Sandwich

Total Genus Sequence Length pdb Title
62 233 5lf4D Human 20s proteasome complex with delanzomib at 2.0 angstrom
60 222 5l6bL Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914
65 211 5l6aK Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
69 244 5l60B Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
53 204 5lf6I Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom
58 195 5l67J Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924
66 200 5lf7K Human 20s proteasome complex with ixazomib at 2.0 angstrom
58 195 5l63J Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
67 216 5lexM Native human 20s proteasome in mg-acetate at 2.2 angstrom
67 250 5l63A Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
61 220 5lf1H Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom
69 242 5l66D Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
76 231 5lm6A Vim-2 metallo-beta-lactamase in complex with 2-(3-fluoro-4-hydroxyphenyl)-3-oxoisoindoline-4-carboxylic acid (compound 35)
70 243 5l6bF Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914
67 233 5l64M Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
62 234 5lezE Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
63 231 5l5vE 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
64 239 5lf0F Human 20s proteasome complex with epoxomicin at 2.4 angstrom
57 195 5l62J Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
67 239 5lf1F Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom
58 204 5l5sI Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924
67 240 5l5vC 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
61 234 5leyE Human 20s proteasome complex with oprozomib at 1.9 angstrom
70 240 5l62C Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
66 216 5lf3M Human 20s proteasome complex with bortezomib at 2.1 angstrom
68 240 5l6aC Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
63 241 5l5yG Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
69 244 5l5vB 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
64 234 5lf0E Human 20s proteasome complex with epoxomicin at 2.4 angstrom
62 220 5lf3H Human 20s proteasome complex with bortezomib at 2.1 angstrom
72 240 5l5xC Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
64 227 5lzp0 Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome
67 242 5l62D Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
65 216 5lezM Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
64 244 5lezG Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
67 213 5lezL Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
61 222 5l63L Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
66 237 5lf3C Human 20s proteasome complex with bortezomib at 2.1 angstrom
61 196 5lttN Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
67 233 5l6bM Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914
65 233 5l5dM Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
55 204 5lf1I Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom
66 239 5lf7F Human 20s proteasome complex with ixazomib at 2.0 angstrom
58 204 5l6cI Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
63 211 5l5tK Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
68 233 5l6cM Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
60 222 5l62L Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
64 237 5lf1C Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom
64 231 5l66E Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
67 250 5l6aA Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17